About Athenese-Dx
Athenese-Dx is a company based in Chennai (India) founded in 2012. It operates as a B2B and D2C. The company has 289 employees as of March 31, 2023. Athenese-Dx offers products and services including Rapid Tests, ELISA Kits, Fluorescence Immuno Assay, Clinical Chemistry, and Molecular PCR Instruments. Athenese-Dx operates in a competitive market with competitors including Inflammatix, MeMed, GenMark Diagnostics, Sunbird Bio and T2 Biosystems, among others.
- Headquarter Chennai, India
- Employees 289 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Athenese-Dx Private Limited
- Date of Incorporation 24 Feb, 2012
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
$8.74 M (USD)-9.63as on Mar 31, 2023
-
Net Profit
$459.89 K (USD)-63.84as on Mar 31, 2023
-
EBITDA
$812.53 K (USD)-39.33as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
289
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Athenese-Dx
Athenese-Dx offers a comprehensive portfolio of products and services, including Rapid Tests, ELISA Kits, Fluorescence Immuno Assay, Clinical Chemistry, and Molecular PCR Instruments.
Quick tests for accurate disease diagnosis in various categories
Kits for reliable enzyme-linked immunosorbent assays
Cost-effective assays for immediate diagnostic results
Products for profiling diabetic, lipid, and cardiac conditions
Instruments for molecular diagnostics and PCR analysis
Funding Insights of Athenese-Dx
Detailed funding history for Athenese-Dx
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Athenese-Dx
Investment portfolio details for Athenese-Dx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Athenese-Dx
Detailed financials for Athenese-Dx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Athenese-Dx Comparisons
Peer comparison for Athenese-Dx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Athenese-Dx
Athenese-Dx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, MeMed, GenMark Diagnostics, Sunbird Bio and T2 Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
|
| Locked | Locked | Locked |
Miniaturized MRI platforms for clinical diagnostics are developed.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
Detailed competitors of Athenese-Dx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Athenese-Dx
Complete news archive for Athenese-Dx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Athenese-Dx
Athenese-Dx was founded in 2012.
Athenese-Dx is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
As of Mar 31, 2023, the latest employee count at Athenese-Dx is 289.
Annual revenue of Athenese-Dx is $8.74M as on Mar 31, 2023.
Athenese-Dx focuses on researching, developing, manufacturing, and marketing in vitro diagnostic tests and instruments. The company offers products like rapid tests, ELISA kits, clinical chemistry, fluorescence immunoassays, and molecular diagnostics. Based in Chennai, India, with a branch in New Delhi, it serves healthcare providers and laboratories globally. Their RD is recognized by the Department of Scientific and Industrial Research, emphasizing quality and innovation in diagnostics.
Athenese-Dx's top competitors include Visby Medical, Inflammatix and MeMed.
Athenese-Dx offers Rapid Tests, ELISA Kits, Fluorescence Immuno Assay, Clinical Chemistry, and Molecular PCR Instruments.